News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
41,561 Results
Type
Article (2662)
Company Profile (25)
Press Release (38873)
Multimedia
Podcasts (14)
Webinars (2)
Section
Business (16018)
Career Advice (79)
Deals (2145)
Drug Delivery (10)
Drug Development (4177)
Employer Resources (10)
FDA (455)
Job Trends (787)
News (20386)
Policy (1052)
Tag
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Standard (1)
Academia (146)
ADA (4)
Allergies (8)
Alliances (3483)
ALS (7)
Alzheimer's disease (77)
Antibody-drug conjugate (ADC) (59)
Approvals (468)
Artificial intelligence (52)
ASCO (16)
Autoimmune disease (34)
Automation (5)
Bankruptcy (13)
Best Places to Work (476)
BIO (12)
BIOSECURE Act (2)
Biosimilars (24)
BioSpace Insights (12)
Biotechnology (17)
Bladder cancer (10)
Brain cancer (9)
Breast cancer (61)
Cancer (454)
Cardiovascular disease (15)
Career advice (66)
Career pathing (1)
CAR-T (50)
CDC (2)
CDMO (6)
Cell therapy (112)
Cervical cancer (7)
Clinical research (3625)
Collaboration (272)
Company closure (4)
Compensation (151)
Complete response letters (1)
COVID-19 (186)
CRISPR (13)
C-suite (188)
Cystic fibrosis (8)
Data (635)
Denatured (6)
Depression (15)
Dermatology (1)
Diabetes (25)
Diagnostics (509)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (55)
Drug pricing (10)
Duchenne muscular dystrophy (65)
Earnings (4806)
Editorial (5)
Employer branding (1)
Employer resources (8)
Events (6727)
Executive appointments (163)
FDA (660)
Friedreich's ataxia (8)
Frontotemporal dementia (1)
Funding (237)
Gene editing (43)
Generative AI (3)
Gene therapy (78)
GLP-1 (79)
Government (163)
Guidances (25)
Healthcare (728)
Hematology (8)
HIV (3)
Huntington's disease (6)
IgA nephropathy (16)
Immunology and inflammation (44)
Immuno-oncology (19)
Indications (11)
Infectious disease (209)
Inflammatory bowel disease (15)
Inflation Reduction Act (6)
Influenza (9)
Intellectual property (43)
Interviews (7)
IPO (1013)
IRA (7)
Job creations (291)
Job search strategy (62)
JPM (4)
Kidney cancer (12)
Labor market (12)
Layoffs (54)
Leadership (3)
Legal (213)
Licensing (1)
Liver cancer (6)
Longevity (6)
Lung cancer (43)
Lymphoma (17)
Machine learning (4)
Management (4)
Manufacturing (87)
MASH (19)
Medical device (317)
Medtech (322)
Mergers & acquisitions (1273)
Metabolic disorders (103)
mRNA (16)
Multiple sclerosis (28)
Neurodegenerative disease (43)
Neuropsychiatric disorders (14)
Neuroscience (223)
NextGen: Class of 2026 (354)
Non-profit (159)
Now hiring (16)
Obesity (48)
Opinion (20)
Ovarian cancer (28)
Pain (37)
Pancreatic cancer (28)
Parkinson's disease (16)
Partnered (4)
Patents (72)
Patient recruitment (61)
Peanut (1)
People (6059)
Pharmaceutical (2)
Phase 1 (1561)
Phase 2 (1783)
Phase 3 (962)
Pipeline (860)
Policy (17)
Postmarket research (30)
Preclinical (670)
Press Release (2)
Prostate cancer (8)
Psychedelics (5)
Radiopharmaceuticals (21)
Rare diseases (100)
Real estate (425)
Recruiting (5)
Regulatory (1001)
Reports (7)
Research institute (149)
Resumes & cover letters (9)
Rett syndrome (4)
RNA editing (6)
RSV (3)
Schizophrenia (18)
Series A (61)
Series B (29)
Sickle cell disease (3)
Special edition (3)
Spinal muscular atrophy (3)
Sponsored (1)
Startups (504)
Stomach cancer (3)
Supply chain (6)
Tariffs (2)
The Weekly (8)
Vaccines (72)
Venture capital (20)
Weight loss (28)
Women's health (25)
Worklife (1)
Date
Today (1)
Last 7 days (42)
Last 30 days (178)
Last 365 days (2415)
2026 (1655)
2025 (2459)
2024 (2606)
2023 (2883)
2022 (3783)
2021 (4069)
2020 (3465)
2019 (2057)
2018 (1548)
2017 (1794)
2016 (1620)
2015 (1829)
2014 (1367)
2013 (1185)
2012 (1392)
2011 (1328)
2010 (1174)
Location
Africa (43)
Alabama (3)
Arizona (21)
Asia (2021)
Australia (310)
California (2148)
Canada (329)
China (121)
Colorado (116)
Connecticut (21)
Delaware (15)
Europe (4133)
Florida (78)
Georgia (19)
Hawaii (2)
Idaho (3)
Illinois (31)
India (6)
Indiana (76)
Japan (24)
Kansas (16)
Kentucky (1)
Louisiana (2)
Maryland (78)
Massachusetts (785)
Michigan (15)
Minnesota (32)
Mississippi (1)
Missouri (6)
Nebraska (1)
Nevada (3)
New Hampshire (4)
New Jersey (178)
New York (117)
North Carolina (167)
Northern California (1109)
Ohio (64)
Oklahoma (2)
Oregon (6)
Pennsylvania (150)
Puerto Rico (1)
Rhode Island (4)
South America (40)
South Carolina (2)
Southern California (872)
Tennessee (6)
Texas (204)
United States (4360)
Utah (7)
Virginia (15)
Washington D.C. (3)
Washington State (116)
West Virginia (1)
Wisconsin (20)
41,561 Results for "aytu bioscience".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aytu BioPharma to Present at the Planet MicroCap Las Vegas 2026 Investor Conference on June 17, 2026
June 2, 2026
·
1 min read
Press Releases
Aytu BioPharma to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
May 18, 2026
·
1 min read
Press Releases
Aytu BioPharma Reports Fiscal 2026 Third Quarter Operational and Financial Results
May 14, 2026
·
24 min read
Press Releases
Aytu BioPharma to Report Fiscal 2026 Third Quarter Operational and Financial Results on May 13, 2026
May 7, 2026
·
1 min read
Press Releases
Aytu BioPharma Reports Fiscal 2026 Second Quarter Operational and Financial Results
February 4, 2026
·
24 min read
Press Releases
Aytu BioPharma Recaps Investor Day Held on January 20, 2026
January 21, 2026
·
29 min read
Press Releases
Aytu BioPharma to Report Fiscal 2026 Second Quarter Operational and Financial Results on February 3, 2026
January 28, 2026
·
1 min read
Press Releases
Aytu BioPharma to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026
January 14, 2026
·
1 min read
Mergers & acquisitions
Argenx deepens immuno expertise with $2.2B Forte Biosciences buy
The star of the takeover is Forte Biosciences’ investigational antibody therapy, FB102, which has shown early potential in vitiligo and celiac disease.
July 27, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Aytu BioPharma to Present at Upcoming October 2025 Conferences
October 13, 2025
·
1 min read
1 of 4,157
Next
